1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) is sponsored by National Institute on Minority Health and Health Disparities (NIMHD), NIH (with partnering NIH centers and institutes).
This funding opportunity aims to engage and support small businesses in providing seed funding for products or services to improve health access or reduce health disparities in NIH-designated populations experiencing health disparities. This includes utilizing cutting-edge digital healthcare and research technologies, such as digital therapeutics, decentralized and digital clinical trials, and remote devices.
Get alerted about grants like this
Get emailed when new opportunities from “National Institute on Minority Health and Health Disparities (NIMHD), NIH (with partnering NIH centers and institutes)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Small businesses located and operating in the United States, with no more than 500 employees, including its affiliates. Prioritizes applications targeting the NIH Minority Health and Health Disparities Strategic Plan. Confirm the full requirements in the official notice before applying.
Applications for Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) are due December 10, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) is funded by National Institute on Minority Health and Health Disparities (NIMHD), NIH (with partnering NIH centers and institutes). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
Elevance Health Foundation's maternal/infant health RFP closes July 31, 2026, part of a five-year, $150 million commitment. Last cycle it awarded 29 grants totaling $6.5M across the pregnancy continuum. Here is what the funder actually rewards — measurable disparity reduction, a 15% indirect-cost cap, and scalable models — plus how nonprofits in the 10 priority states should frame a competitive proposal.
Read articleThe joint NSF-NIH Smart Health and Biomedical Research solicitation supports high-risk, high-reward AI/data science work in health — $300K per year for four years, with 20+ NIH institutes participating. Here is how the program actually selects winners.
Read articleNIH is investing $130 million over four years to turn biomedical datasets into AI-ready infrastructure. Here is what Stage 2 funds, who should apply, and why the program matters more than its budget suggests.
Read article